For: | Mak LY, To WP, Wong DKH, Fung J, Liu F, Seto WK, Lai CL, Yuen MF. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients. World J Gastroenterol 2019; 25(11): 1398-1408 [PMID: 30918432 DOI: 10.3748/wjg.v25.i11.1398] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v25/i11/1398.htm |
Number | Citing Articles |
1 |
Kantoku Nagakawa, Masaaki Hidaka, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Takayuki Tanaka, Tomohiko Adachi, Akihiko Soyama, Kengo Kanetaka, Susumu Eguchi, Jincheng Wang. Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis. PLOS ONE 2023; 18(11): e0293593 doi: 10.1371/journal.pone.0293593
|
2 |
Lung-Yi Mak. Disease modifiers and novel markers in HBV-related HCC. Journal of Liver Cancer 2024; doi: 10.17998/jlc.2024.08.03
|
3 |
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, Tung-Hung Su, Chia-Chi Wang, Chun-Jen Liu, Hung-Chih Yang, Wan-Ting Yang, Chia-Hsin Lin, Ming-Lung Yu, Hsueh-Chou Lai, Yasuhito Tanaka, Mindie H. Nguyen, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. Liver Cancer 2020; 9(2): 207 doi: 10.1159/000504650
|
4 |
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. Journal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
|
5 |
Lung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, Rex Wan-Hin Hui, Fen Liu, James Fung, Wai-Kay Seto, Man-Fung Yuen. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection. Digestive Diseases and Sciences 2022; 67(11): 5127 doi: 10.1007/s10620-022-07429-4
|
6 |
Chih-Lin Lin, Jia-Horng Kao. Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection. Clinical and Molecular Hepatology 2023; 29(3): 605 doi: 10.3350/cmh.2022.0342
|
7 |
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 2021; 13(7): 1333 doi: 10.3390/v13071333
|
8 |
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. International Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949
|
9 |
Shu Feng, Zhonghao Wang, Yanhua Zhao, Chuanmin Tao. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67471-y
|
10 |
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
|
11 |
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2023; : 31 doi: 10.1016/B978-0-323-98368-6.00009-4
|